Rationale for a Pharmacists' Pharmacopeia
Download in electronic PDF format for $65
Abstract: The author, chair of the United States Pharmacopeia Expert Committee on Nonsterile Pharmacy Compounding, provides background on the United States Pharmacopeia (USP) and discusses the role of the USP, quality, education, dispensing, costs, market, composition and concerns. To summarize, it is evident that it is time for the USP to address the needs of the practice of pharmacy with a Pharmacists’ Pharmacopeia.
Related Keywords:
Allen, Loyd V. Jr, PhD, RPh, United States Pharmacopeia, background and role of, USP, background and role of
Related Categories:
BUSINESS, SUPPORT, PHARMACY EDUCATION, UNITED STATES PHARMACOPEIA CONVENTIONS
Printer-Friendly Version
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Healthful Living: Good Practices for Good Health
Jackson Kathy
|
May/Jun 2002
Pg. 164-166
|
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 92
|
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Allen Loyd V Jr
|
May/Jun 2020
Pg. 180
|
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 449-450
|
Rationale for a Pharmacists' Pharmacopeia
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 285-287
|
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
|
Mar/Apr 2021
Pg. 115-124
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 146-150
|
PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 92
|
PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives
Allen Loyd V Jr
|
May/Jun 2017
Pg. 180
|
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr, Okeke Claudia C
|
Sep/Oct 2007
Pg. 404-410
|
